https://www.pharmaradar360.com/article/566322c8b5c66c6dPharmaRadar360en2026-04-03T12:26:00.000ZOffering scientists cash to spot errors in published papers doesn’t workhttps://www.pharmaradar360.com/article/627f15bbcb0fdfc1PharmaRadar360en2026-04-03T10:00:00.000ZTrastuzumab Deruxtecan in Residual HER2-Positive Early Breast Cancerhttps://www.pharmaradar360.com/article/33b3bcb4e1140024PharmaRadar360en2026-04-03T10:00:00.000ZThe Fetal-to-Adult Hemoglobin Switch - Mechanism and Therapyhttps://www.pharmaradar360.com/article/9813c00f3d9cfc61PharmaRadar360en2026-04-03T10:00:00.000ZDigital Twin-Guided Ablation for Ventricular Tachycardiahttps://www.pharmaradar360.com/article/5d9e823dc8e3fe97PharmaRadar360en2026-04-03T10:00:00.000ZMore Options for Gene Editing in Hemoglobinopathieshttps://www.pharmaradar360.com/article/72aa42f03ef82756PharmaRadar360en2026-04-03T10:00:00.000ZMinocycline-Induced Hyperpigmentationhttps://www.pharmaradar360.com/article/0df37fb116a544faPharmaRadar360en2026-04-03T10:00:00.000ZClinical Examination of the Lumbar Spinehttps://www.pharmaradar360.com/article/e7cf70146008dacaPharmaRadar360en2026-04-03T10:00:00.000ZGLP-1 Receptor Agonistshttps://www.pharmaradar360.com/article/88f41ecbec272468PharmaRadar360en2026-04-03T10:00:00.000ZErratum: Tissue-Free Circulating Tumor DNA Assay and Patient Outcome in a Phase III Trial of FOLFOX-Based Adjuvant Chemotherapy (Alliance N0147)https://www.pharmaradar360.com/article/b8072a374bbedbc9PharmaRadar360en2026-04-03T03:00:00.000Z[SHINSA]English translation of review report: Peripheral Rotablator PRO and Visual-ICE Cryoablation System (Partial Change Approval)